Revolution Medicines CEO Mark Goldsmith on new Pancreatic cancer drug breakthrough
Corroborated by 2 sources from 2 publishers
TL;DR
Reports differ across sources; according to cnbc.com, watch now Revolution Medicines CEO Mark Goldsmith on new Pancreatic cancer drug breakthrough Revolution Medicines CEO Mark Goldsmith sits down with CNBC's Angelica Peebles at the American Society of Clinical Oncology's annual meeting to discuss its new Pancreatic cancer drug breakthrough, submitting FDA application for the drug, and more.
Sources
1
Seeking Alpha Market News
https://seekingalpha.com/article/4910497-revolution-medicines-inc-rvmd-discusses-positive-clinical-results-and-implications-for?source=feed_all_articles
2
CNBC 15838381
https://www.cnbc.com/video/2026/06/01/revolution-medicines-ceo-mark-goldsmith-on-new-pancreatic-cancer-drug-breakthrough.html